238 related articles for article (PubMed ID: 27875502)
21. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
22. Clinical application of volatile organic compound analysis for detecting infectious diseases.
Sethi S; Nanda R; Chakraborty T
Clin Microbiol Rev; 2013 Jul; 26(3):462-75. PubMed ID: 23824368
[TBL] [Abstract][Full Text] [Related]
23. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
[TBL] [Abstract][Full Text] [Related]
24. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
25. Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath.
Haworth JJ; Pitcher CK; Ferrandino G; Hobson AR; Pappan KL; Lawson JLD
Crit Rev Clin Lab Sci; 2022 Aug; 59(5):353-372. PubMed ID: 35188863
[TBL] [Abstract][Full Text] [Related]
26. Application of Electronic-Nose Technologies and VOC-Biomarkers for the Noninvasive Early Diagnosis of Gastrointestinal Diseases
Wilson AD
Sensors (Basel); 2018 Aug; 18(8):. PubMed ID: 30096939
[TBL] [Abstract][Full Text] [Related]
27. Sniffing animals as a diagnostic tool in infectious diseases.
Cambau E; Poljak M
Clin Microbiol Infect; 2020 Apr; 26(4):431-435. PubMed ID: 31734357
[TBL] [Abstract][Full Text] [Related]
28. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
[TBL] [Abstract][Full Text] [Related]
29. Review article: next generation diagnostic modalities in gastroenterology--gas phase volatile compound biomarker detection.
Arasaradnam RP; Covington JA; Harmston C; Nwokolo CU
Aliment Pharmacol Ther; 2014 Apr; 39(8):780-9. PubMed ID: 24612215
[TBL] [Abstract][Full Text] [Related]
30. Exhaled breath analysis for the diagnosis and assessment of endoluminal gastrointestinal diseases.
Markar SR; Wiggins T; Kumar S; Hanna GB
J Clin Gastroenterol; 2015 Jan; 49(1):1-8. PubMed ID: 25319742
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
[TBL] [Abstract][Full Text] [Related]
32. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
33. Real time analysis of volatile organic compounds (VOCs) in centenarians.
Mazzatenta A; Pokorski M; Di Giulio C
Respir Physiol Neurobiol; 2015 Apr; 209():47-51. PubMed ID: 25542135
[TBL] [Abstract][Full Text] [Related]
34. Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases.
Belizário JE; Faintuch J; Malpartida MG
Front Cell Infect Microbiol; 2020; 10():564194. PubMed ID: 33520731
[TBL] [Abstract][Full Text] [Related]
35. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
36. Volatile disease biomarkers in breath: a critique.
Kwak J; Preti G
Curr Pharm Biotechnol; 2011 Jul; 12(7):1067-74. PubMed ID: 21466456
[TBL] [Abstract][Full Text] [Related]
37. Saliva - Volatile Biomarkers and Profiles.
Milanowski M; Pomastowski P; Ligor T; Buszewski B
Crit Rev Anal Chem; 2017 May; 47(3):251-266. PubMed ID: 27905825
[TBL] [Abstract][Full Text] [Related]
38. Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
Nakhleh MK; Haick H; Humbert M; Cohen-Kaminsky S
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232412
[TBL] [Abstract][Full Text] [Related]
39. Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers.
Wilson AD; Forse LB
Sensors (Basel); 2023 Mar; 23(6):. PubMed ID: 36991597
[TBL] [Abstract][Full Text] [Related]
40. Strategies for the identification of disease-related patterns of volatile organic compounds: prediction of paratuberculosis in an animal model using random forests.
Kasbohm E; Fischer S; Küntzel A; Oertel P; Bergmann A; Trefz P; Miekisch W; Schubert JK; Reinhold P; Ziller M; Fröhlich A; Liebscher V; Köhler H
J Breath Res; 2017 Nov; 11(4):047105. PubMed ID: 28768897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
